Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Lymphomes non hodgkinien
- | Specialty :
- Thérapies Ciblées
- Immunothérapie - Vaccinothérapie
Extract
ITSELF: Phase Ib study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (Selicrelumab) in combination with anti-PD-L1 (Atezolizumab) in patients with refractory or relapsed B cell lymphoma